Rigel Pharmaceuticals, Inc. (RIGL) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 48.86 -0.02 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.88 | 52 Week High | $4.38 | |||
| Open | $48.97 | 52 Week Low | $1.88 | |||
| Day High | $49.94 | P/E | N/A | |||
| Day Low | $48.55 | EPS | $-1.12 | |||
| Volume | 152,638 | |||||
